inflammatory disease – CFN Media

Healthcare Stocks

Cardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association

Results demonstrate CardiolRx™ may represent a paradigm shift in the treatment of…

Ryan Allway
May 7, 2026

Healthcare Stocks

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board

Mr. Allan, the 2017 winner of the prestigious Julia Levy Award, to…

Ryan Allway
April 21, 2022

FSD Pharma’s Team Advancing a New Approach to Multiple Sclerosis

Multiple sclerosis, or MS, is a degenerative neurological disorder that makes life…

Robin Lefferts
April 20, 2022

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Stella Emory

Wilson Augustine

Tech Stocks

MBody AI Doubles Deployment at Major Northeast Casino & Entertainment Destination

Nasdaq-listed physical AI company grows it’s support at Mohegan Sun’s…

Ryan Allway
November 5, 2026

Bioxytran Secures Attested Free Sale Certification for A-SUQAR®, Opening the Path to the UAE and Gulf Markets

Non-systemic, pre-meal chewable nutraceutical designed to help blunt post-meal blood…

Ryan Allway
November 4, 2026

Graphite One Secures Final Ohio Air Permit, Supporting Further Progress towards Planned Construction for US$80 Million Phase 1 Anode Plant

Ten-year permit covers the planned 10,000-tonne-per-year Phase 1 in Conneaut, Ohio…

Ryan Allway
November 2, 2026

Opportunity: The United States Still Needs A Lot of Domestic Lithium

A few years ago, lithium was the darling of the global investment…

Robin Lefferts
October 29, 2026